<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Felix</title>
    <link>https://old.felixonline.co.uk/authors/cm1410/</link>
    <description>Recent content on Felix</description>
    <atom:link href="https://old.felixonline.co.uk/authors/cm1410/" rel="self" type="application/rss+xml" />
    
      <item>
        <title>The Business of British Biotechnology
</title>
        <link>https://old.felixonline.co.uk/articles/2011-11-10-the-business-of-british-biotechnology/</link>
        <pubDate>Thu, 10 Nov 2011 21:26:10 +0000</pubDate>
        
          <author>Charles Motraghi,</author>
        
        <guid>https://old.felixonline.co.uk/articles/2011-11-10-the-business-of-british-biotechnology/</guid>
        <description>Alongside finance and high-tech computing, biotechnology can be thought of as one of the few sectors where Britain is still globally competitive. The British pharmaceutical industry, for example, receives 10% of global research and development funding, despite having only 3% of global sales. But â€¦</description>
      </item>
    
  </channel>
</rss>
